Why The FLOAT Study Matters
Non-invasive nutritional intervention
Understanding the Problem: Vitreous Floaters
The Problem:
Vitreous floaters are small clumps of collagen or cellular debris that form inside the clear gel (vitreous) of the eye. They cast shadows on the retina and appear as spots, threads, or cobwebs that drift across your vision.
Floaters are incredibly common — studies estimate that more than 75% of people over age 60 experience them, and even younger adults can develop floaters after eye injuries, surgery, or simply due to natural aging of the vitreous.
While many floaters are mild and fade into the background, for some people they become distracting, frustrating, and interfere with reading, driving, or enjoying daily life.
The Challenge: Limited Treatment Options
Despite how common and bothersome floaters can be, there is no widely-accepted, non-invasive treatment available today.
Eye doctors generally take a “watch and wait” approach, only offering treatment when floaters severely impact vision. Currently, there are two options:
Pars plana vitrectomy (PPV): A surgical procedure that removes the vitreous gel entirely. It is effective but carries significant risks like retinal detachment, infection, or cataract.
YAG laser vitreolysis: A laser treatment that can break up floaters but is not suitable for everyone and may not eliminate them completely. Results are variable and long-term safety is still under study.
For the vast majority of patients, doctors simply tell them to live with it.
A New Approach:
The FLOAT Study
We believe that a safer, evidence-based alternative is possible.
We have reviewed and analyzed results from multiple clinical studies that investigated the impact of specific nutrients — such as antioxidants, enzymes, and amino acids — on vitreous health. Using this research, we have developed a targeted, AI‑optimized nutritional supplement specifically designed to support vitreous clarity and reduce the impact of floaters.
But formulating a supplement is only part of the story — we also need to rigorously test it. That’s where The FLOAT Study comes in.
Why Our Study is Different: Objective Measurements
One of the biggest challenges in floater research has been measuring results objectively.
Previous studies relied heavily on subjective questionnaires — asking patients if they “felt better.”
But symptoms can fluctuate and perceptions vary widely.
The FLOAT Study will be the first study to use the Objective Scatter Index (OSI) measured by the HD Analyzer to quantify the amount of light scatter in the eye caused by floaters.
The HD Analyzer uses advanced double-pass wavefront technology to objectively measure how much scatter is occurring in the eye — and provides a numerical score that can be tracked over time. This allows us to:
Quantify improvements more accurately.
Eliminate guesswork and bias from subjective reports.
Show, in measurable terms, whether the supplement improves optical quality.
By combining subjective feedback with objective OSI measurements and clinical imaging, our study sets a new standard for rigor in floater research.
Our Goal
We aim to demonstrate that targeted nutritional support — grounded in prior research and optimized for floater sufferers — can improve visual quality and reduce the burden of floaters.
The FLOAT Study isn’t just about testing a supplement — it’s about providing hope, evidence, and a path forward for millions of people who have been told “there’s nothing you can do.”
